Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Terminated Phase 2 Trials for Busulfan (DB01008)

Indication	Status	Phase
DBCOND0028499 (Recurrent Adult Diffuse Small Cleaved Cell Lymphoma)	Terminated	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01044745	Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer	Treatment	Antilymphocyte immunoglobulin (horse) (DB09312) Antithymocyte immunoglobulin (rabbit) (DB00098) Busulfan (DB01008) Cyclophosphamide (DB00531) Fludarabine (DB01073) Mycophenolate mofetil (DB00688) Rituximab (DB00073) Tacrolimus (DB00864)